Docusign vaulted up ~15% higher after a strong Q4 earnings print, featuring a re-acceleration in billings growth to 11% y/y and an improvement in net retention rates. The company benefits from large ...

Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...